Changes in Lung Physiology and Cardiac Performance in Patients With Emphysema Post Bilateral RePneu Coil Treatment

NCT02499380 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2021-07-19

Study results available
· View outcomes & findings →

Summary

The objective of this post-marketing study is to advance the understanding of the mechanism of action of the CE marked RePneu Coil by observing changes in lung physiology and cardiac performance in patients with emphysema treated with the RePneu Coils, when used as intended.

Conditions

  • Emphysema

Interventions

DEVICE

PneumRx Coil System

Sponsors & Collaborators

  • PneumRx, Inc.

    collaborator INDUSTRY
  • Boston Scientific Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-09
Primary Completion
2017-12-08
Completion
2018-10-20

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02499380 on ClinicalTrials.gov